Prostate Health Market Size, Share & Trends Analysis Report By Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia (BPH) treatments such as Alpha Blockers and 5-Alpha Reductase Inhibitors (5-ARIs), Prostatitis), By Treatment, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Prostate Health Market Snapshot Chapter 4. Global Prostate Health Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Disease Indication Estimates & Trend Analysis 5.1. by Disease Indication & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Disease Indication: 5.2.1. Prostate Cancer 5.2.1.1. AR-directed Therapies 5.2.1.2. Hormone ADT 5.2.1.3. Cytotoxic Agents 5.2.1.4. PARP Inhibitors 5.2.1.5. Other Therapies 5.2.2. Benign Prostatic Hyperplasia (BPH) 5.2.2.1. Alpha Blockers 5.2.2.1.1. Tamsulosin 5.2.2.1.2. Silodosin 5.2.2.1.3. Alfuzosin 5.2.2.1.4. Doxazosin 5.2.2.1.5. Other Alpha Blockers 5.2.2.2. 5-Alpha Reductase Inhibitors (5-ARIs) 5.2.2.2.1. Dutasteride 5.2.2.2.2. Finasteride 5.2.2.2.3. Other Drug Classes 5.2.3. Prostatitis 5.2.4. Prescription Products 5.2.5. Over-the-Counter Products Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis 6.1. by Treatment & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Treatment: 6.2.1. Hormone ADT 6.2.2. AR Directed Therapies 6.2.3. PARP Inhibitors 6.2.4. Others Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis 7.1. by Distribution Channel & Market Share, 2024 & 2034 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel: 7.2.1. Pharmacy 7.2.2. E-commerce Stores 7.2.3. Others Chapter 8. Prostate Health Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Prostate Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034 8.1.2. North America Prostate Health Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2021-2034 8.1.3. North America Prostate Health Market revenue (US$ Million) by Distribution Channel, 2021-2034 8.1.4. North America Prostate Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.2. Europe 8.2.1. Europe Prostate Health Market revenue (US$ Million) by Disease Indication, 2021-2034 8.2.2. Europe Prostate Health Market revenue (US$ Million) by Treatment, 2021-2034 8.2.3. Europe Prostate Health Market revenue (US$ Million) by Distribution Channel, 2021-2034 8.2.4. Europe Prostate Health Market revenue (US$ Million) by country, 2021-2034 8.3. Asia Pacific 8.3.1. Asia Pacific Prostate Health Market revenue (US$ Million) by Disease Indication, 2021-2034 8.3.2. Asia Pacific Prostate Health Market revenue (US$ Million) by Treatment, 2021-2034 8.3.3. Asia-Pacific Prostate Health Market revenue (US$ Million) by Distribution Channel, 2021-2034 8.3.4. Asia Pacific Prostate Health Market revenue (US$ Million) by country, 2021-2034 8.4. Latin America 8.4.1. Latin America Prostate Health Market revenue (US$ Million) by Disease Indication, 2021-2034 8.4.2. Latin America Prostate Health Market revenue (US$ Million) by Treatment, 2021-2034 8.4.3. Latin America Prostate Health Market revenue (US$ Million) by Distribution Channel, 2021-2034 8.4.4. Latin America Prostate Health Market revenue (US$ Million) by country, 2021-2034 8.5. Middle East & Africa 8.5.1. Middle East & Africa Prostate Health Market revenue (US$ Million) by Disease Indication, 2021-2034 8.5.2. Middle East & Africa Prostate Health Market revenue (US$ Million) by Treatment, 2021-2034 8.5.3. Middle East & Africa Prostate Health Market revenue (US$ Million) by Distribution Channel, 2021-2034 8.5.4. Middle East & Africa Prostate Health Market revenue (US$ Million) by country, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Pfizer Inc. 9.2.2. Lily 9.2.3. Bayer AG 9.2.4. Abbolt 9.2.5. GSK plc. 9.2.6. Merck KgaA 9.2.7. ProArc 9.2.8. Nucleai, Inc. 9.2.9. Sanofi 9.2.10. AbbVie Inc 9.2.11. Other Prominent Players